How should a patient taper off a 75 mg dose of venlafaxine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Taper Off 75mg Venlafaxine

Taper venlafaxine gradually by reducing the dose by 37.5 mg every 4-7 days, taking at least 2-4 weeks to discontinue completely, as abrupt cessation causes a well-documented withdrawal syndrome that can be severe.

Why Tapering is Essential

Venlafaxine must be tapered when discontinuing because withdrawal syndrome is well-established 1. The FDA label explicitly warns that "abrupt discontinuation can be associated with certain symptoms" and recommends tapering "as rapidly as is feasible" while recognizing discontinuation risks 2. Multiple guidelines consistently emphasize this requirement 3.

The withdrawal syndrome from venlafaxine can include:

  • Physical symptoms: Headache, nausea, dizziness, fatigue, flu-like symptoms, sensory disturbances
  • Psychological symptoms: Anxiety, agitation, dysphoria, irritability, crying spells
  • In severe cases: Hallucinations (documented in case reports) 4

Recommended Tapering Schedule

Starting from 75 mg daily:

  1. Week 1-2: Reduce to 37.5 mg daily (50% reduction)
  2. Week 2-4: Continue 37.5 mg daily to stabilize
  3. Week 4+: Discontinue after at least 4 days at 37.5 mg

Key principles:

  • Make dose reductions of 37.5 mg increments (the smallest available dose)
  • Wait at least 4 days between reductions 1
  • The entire taper should take 2-4 weeks minimum 5
  • For patients on venlafaxine longer-term (months to years), consider slower tapers (up to several weeks to months) 6

Critical Warnings

Do NOT Use Alternate-Day Dosing

Never taper by taking venlafaxine every other day. This approach causes severe fluctuations in drug levels and receptor occupancy, dramatically increasing withdrawal risk 7. Venlafaxine has a short half-life, making it particularly unsuitable for alternate-day dosing strategies.

Monitor Closely During Tapering

Watch for withdrawal symptoms including:

  • Dizziness and light-headedness
  • Nausea and vomiting
  • Headache
  • Anxiety or agitation
  • Sensory disturbances

If moderate-to-severe withdrawal symptoms emerge:

  • Reinstate the previous dose immediately
  • Stabilize for 1-2 weeks
  • Resume tapering at a slower rate (smaller decrements or longer intervals)

Special Considerations

Venlafaxine is particularly prone to withdrawal compared to other antidepressants due to its short elimination half-life 3, 4. Research shows that "severe discontinuation reactions may occur with venlafaxine, seemingly marked most distinctly by headache, nausea, fatigue, dizziness and dysphoria, and may make cessation of the drug extremely difficult" 4.

If withdrawal symptoms are intolerable despite slow tapering:

  • Consider switching to a longer-acting antidepressant (like fluoxetine) before final discontinuation
  • Use liquid formulations if available for more gradual dose reductions
  • Some patients may require tapering over several months 5

Patient education is essential: Explain that withdrawal symptoms are:

  • Usually transient (1-3 days to weeks)
  • Self-limiting in most cases
  • Not a sign of addiction
  • Distinct from depression relapse (though can be mistaken for it) 5

Practical Implementation

From 75 mg daily, the most practical approach uses available tablet strengths:

  • Days 1-7: Take 37.5 mg daily (one 37.5 mg tablet)
  • Days 8-14: Continue 37.5 mg daily
  • Days 15-21: Continue 37.5 mg daily (optional extension if needed)
  • Day 22+: Discontinue

If only 75 mg tablets are available, consider obtaining 37.5 mg tablets specifically for tapering, or discuss with a pharmacist about splitting tablets if appropriate for the formulation.

The first dose reduction is critical - if it goes poorly, slow down immediately 8. Most patients can tolerate this schedule, but approximately 10-25% may need slower tapers based on individual sensitivity 4, 5.

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Research

Withdrawal reactions associated with venlafaxine.

The Australian and New Zealand journal of psychiatry, 1998

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Guideline

prevention and control of seasonal influenza with vaccines.

MMWR Recommendations and Reports, 2016

Research

Antidepressant Tapering Is Not Routine But Could Be.

Journal of the American Board of Family Medicine : JABFM, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.